The US presidential election on Nov. 5 bring significant risks and opportunities for the health-care industry, with insurers, pharmaceutical companies and hospitals all watching for possible changes in programs such as Obamacare and Medicare. In this edition of the Votes and Verdicts podcast, Bloomberg Intelligence analysts Duane Wright, Glen Losev and Michael Shah discuss the potential impact of the US presidential and congressional elections on the industry. They cover key issues such as Medicare coverage of obesity drugs, the IRA drug-negotiation program and government funding of health-care coverage, among others.